TAVR has transformed the treatment of aortic stenosis — procedural success rates are high, and early mortality has declined significantly. But procedural success doesn't guarantee post-discharge success.
Despite a successful valve replacement, a meaningful share of patients are readmitted within 90 days, and roughly two-thirds of deaths in this population are non-cardiac — driven by infection and systemic decline that standard care isn't built to catch.
The valve gets fixed. The patient doesn't automatically become invisible to risk. Synchronize Health's SYNC-PREVENT™ framework closes that gap by transitioning every TAVR patient into continuous Clinical Status Monitoring at discharge — not just the ones who already look high-risk.
The program layers hemodynamic monitoring with Vivio, rhythm monitoring with an ECG patch through the first month and then Kardia through day 90, and home-device tracking of weight, blood pressure, heart rate, and SpO₂ against parameters the ordering physician defines — all reviewed by the physician across the window where systemic decline does the most damage and gets watched the least. Cardiac rhythm data collected by cleared cardiac devices is transmitted to the treating physician for clinical review — including findings related to atrial fibrillation, bradyarrhythmia patterns, and conduction-related measurements — and longitudinal daily data supports the physician in reviewing trends in patient status across monitoring periods.
Infection-risk review doesn't rely on temperature alone. Structured temperature measurement data is collected and transmitted for physician review, and provider-ordered biomarker testing adds a second, independent data stream — using labs many patients are already having drawn, with no additional testing required.
Two independent data streams for the physician's infection-risk assessment — structured device-based temperature measurement and provider-ordered biomarker testing — instead of relying on either one alone.
TAVR solves the valve. Synchronize Health extends visibility, reduces uncertainty, and enables earlier intervention — for everything after.